✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
But in some cases, severe symptoms may persist despite the bronchodilators and corticosteroids.We describe the first case of a patient with RADS, unresponsive to all medical agents, who was successfully treated with lidocaine
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Reactive airway dysfunction syndrome (RADS) is a variant of irritant-induced asthma that develops in subjects without prior bronchoobstructive disease, following high-level exposure to nonimmunogenic irritants.
📊
Key Findings & Data:Recommended maintenance treatment for RADS is not different from asthma.
💡
Conclusion & Impact:But in some cases, severe symptoms may persist despite the bronchodilators and corticosteroids.We describe the first case of a patient with RADS, unresponsive to all medical agents, who was successfully treated with lidocaine
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Reactive airway dysfunction syndrome (RADS) is a variant of irritant-induced asthma that develops in subjects without prior bronchoobstructive disease, following high-level exposure to nonimmunogenic irritants. Recommended maintenance treatment for RADS is not different from asthma. But in some cases, severe symptoms may persist despite the bronchodilators and corticosteroids.We describe the first case of a patient with RADS, unresponsive to all medical agents, who was successfully treated with lidocaine
🔖
Cite This Article
KIYAN, E., ÇAĞATAY, T., OKUMUŞ, G., ERKAN, F., ÖZYİĞİT, L. P., ERER, A. (2022). Nebulized Lidocaine as an Alternative Therapy for Reactive Airway Dysfunction Syndrome. Turkish Thoracic Journal, Cilt: 17 - Sayı: 2, 82–83. https://ajindex.com/articles/618134